0000899243-20-032868.txt : 20201207 0000899243-20-032868.hdr.sgml : 20201207 20201207163009 ACCESSION NUMBER: 0000899243-20-032868 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201203 FILED AS OF DATE: 20201207 DATE AS OF CHANGE: 20201207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ezekowitz Alan CENTRAL INDEX KEY: 0001780209 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38978 FILM NUMBER: 201373047 MAIL ADDRESS: STREET 1: C/O FULCRUM THERAPEUTICS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-03 0 0001680581 Fulcrum Therapeutics, Inc. FULC 0001780209 Ezekowitz Alan C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE CA 02139 1 0 0 0 Stock Option (right to buy) 11.82 2020-12-03 4 A 0 15000 0.00 A 2030-12-02 Common Stock 15000 15000 D This option was granted on December 3, 2020 and is scheduled to vest with respect to all shares on November 2, 2021, subject to continued service. /s/ Peter Thomson, as attorney-in-fact for Alan Ezekowitz 2020-12-07